Bloomios

Bloomios Operating Expenses

The Total Operating Expenses of Bloomios (BLMS) as of Nov 2, 2026 is 6.88 M USD. In the previous year, Total Operating Expenses was 5.87 M USD — a change of 17.20% (higher).

Operating Expenses

6.88 MUSD

YoY

17.20%

Last updated:

Total Operating Expenses of Bloomios is 2023 6.88 M USD. Total Operating Expenses of Bloomios was 2022 5.87 M USD. It decreases by 17.20% higher compared to the previous year.

The Bloomios Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
10,000.00 USD
Jan 1, 2019
466,434.00 USD
Jan 1, 2020
16,863.00 USD
Jan 1, 2021
1.73 M USD
Jan 1, 2022
5.87 M USD
Jan 1, 2023
6.88 M USD
The Bloomios Operating Expenses history
YEAROperating ExpensesYoY
6.88 MUSD+17.20%
5.87 MUSD+239.99%
1.73 MUSD+10,135.11%
16,863.00USD-96.38%
466,434.00USD+4,564.34%
10,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bloomios Stock analysis

What does Bloomios do? Bloomios, Inc. generates revenue through the wholesale distribution of U.S. hemp-derived supplements and cosmetic products. The company manufactures and distributes hemp-infused edibles, pet edibles, tinctures, shots, topicals, smokable hemp, and other products across seven categories including edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. BPL, a subsidiary of Bloomios, focuses on manufacturing and distributing hemp-derived nootropic and nutraceutical products to wholesalers and retailers. Bloomios provides private-label and white-label services with over 80 customizable products and custom formulation and manufacturing support for its customers. The company's primary customers are wholesalers and retailers who purchase its hemp-derived products for resale. Bloomios offers a comprehensive suite of services including custom formulation, order fulfillment, and brand development to support its clients. Its product portfolio spans multiple categories such as human edibles, pet edibles, liquid consumables, topicals, and smokable hemp, catering to both consumer and pet markets. Bloomios leverages its subsidiary BPL to expand its product offerings in the hemp-derived nootropic and nutraceutical sectors. The company's focus on customizable solutions allows it to serve a diverse range of clients seeking private-label and white-label hemp products. Through its wholesale distribution channels, Bloomios targets businesses looking to sell hemp-based supplements and cosmetics under their own brand names. Bloomios is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bloomios stock

Total Operating Expenses of Bloomios is 6.88 M USD in 2023.

Total Operating Expenses of Bloomios changed from 5.87 M USD to 6.88 M USD, representing a 17.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Bloomios since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Bloomios historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Bloomios

All Key Metrics — Bloomios